Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma

Molecular and Cellular Biochemistry

Volumn 375, Issue 1-2, 2013, Pages 23-30

  Gu, Hao ^a   Guo, Xiaodong ^b   Zou, Lin ^c   Zhu, Haiyan ^c   Zhang, Jinhui ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell proliferation; Hepatocellular carcinoma; Invasion; MicroRNA 372; Migration; Overall survival; Recurrence free survival

Indexed keywords

MICRORNA; MICRORNA 372; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; UP-REGULATION;

EID: 84873059856     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1521-6     Document Type: Article

References (23)

1. Poon D, Anderson BO, Chen LT et al (2009) Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10:1111-1118
2. Aravalli RN, Steer CJ, Cressman EN (2008) Molecular mechanisms of epatocellular carcinoma. Hepatology 48:2047-2063
3. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576
4. Barshack I, Meiri E, Rosenwald S et al (2010) Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. Int J Biochem Cell Biol 42:1355-1362
5. Villanueva A, Hoshida Y, Toffanin S et al (2010) New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res 16:4688-4694
6. Negrini M, Gramantieri L, Sabbioni S, Croce CM (2011) microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 11:500-521
7. Milazzo M, Fornari F, Gramantieri L (2011) MicroRNA and hepatocellular carcinoma: biology and prognostic significance. Minerva Gastroenterol Dietol 57:257-271
8. Li D, Liu X, Lin L et al (2011) MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 286:36677-36685
9. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28:3526-3536
10. Li Y, Kowdley KV (2012) Cellular microRNA and the tumorigenesis of hepatocellular carcinoma. Ann Hepatol 11:272-274
11. Wong CM, Wong CC, Lee JM, Fan DN, Au SL, Ng IO (2012) Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology 55:1453-1461
12. Ji J, Zhao L, Budhu A et al (2010) Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52:690-697
13. Nishida N, Goel A (2011) Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 12:130-137
14. Wang B, Majumder S, Nuovo G et al (2009) Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 50:1152-1161
15. Li QJ, Zhou L, Yang F, et al. (2012) MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells. Tumour Biol, In press
16. Roa W, Brunet B, Guo L et al (2010) Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 33:E124
17. Wang Y, Lee CG (2011) Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? Epigenomics 3:235-243
18. Voorhoeve PM, le Sage C, Schrier M et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124:1169-1181
19. Cho WJ, Shin JM, Kim JS et al (2009) miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 28:521-527
20. Yu SL, Chen HY, Chang GC et al (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48-57
21. Lai JH, She TF, Juang YM et al (2012) Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0)expressing miR-372. Electrophoresis 33:675-688
22. Yamashita S, Yamamoto H, Mimori K et al (2012) MicroRNA-372 Is Associated with Poor Prognosis in Colorectal Cancer. Oncology 82:205-212
23. Tian RQ, Wang XH, Hou LJ et al (2011) MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J Biol Chem 286:25556-25563